What is the main purpose of the newly developed AI technology by Hitachi?

The AI technology is designed to support the pre-preparation of Expert Panels (EP) in cancer genomic medicine by presenting points for confirmation and discussion.

What kind of information does the AI technology utilize to generate its suggestions?

The AI technology refers to past physician comments, related knowledge, and literature databases to generate its suggestions for the Expert Panels.

What are the expected benefits of implementing this AI technology in cancer genomic medicine?

The technology is expected to facilitate smoother EP discussions, reduce pre-preparation time for information gathering, and alleviate the workload of physicians.

How does the AI system ensure the security of sensitive patient information?

The system is designed to operate on PCs within the hospital, ensuring that no sensitive information is transmitted externally.

What was the outcome of the evaluation conducted using past cases from Tohoku University Hospital?

In an evaluation using past cases, over 80% of the points presented by the AI technology for EP confirmation and discussion matched the EP's review results regarding treatment policies.

AI News NQ Analysis

Hitachi Develops AI Technology to Support Pre-preparation for Expert Panels in Cancer Genomic Medicine

NQ Score 56/100

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the main purpose of the newly developed AI technology by Hitachi?: A: The AI technology is designed to support the pre-preparation of Expert Panels (EP) in cancer genomic medicine by presenting points for confirmation and discussion.
Q: What kind of information does the AI technology utilize to generate its suggestions?: A: The AI technology refers to past physician comments, related knowledge, and literature databases to generate its suggestions for the Expert Panels.
Q: What are the expected benefits of implementing this AI technology in cancer genomic medicine?: A: The technology is expected to facilitate smoother EP discussions, reduce pre-preparation time for information gathering, and alleviate the workload of physicians.
Q: How does the AI system ensure the security of sensitive patient information?: A: The system is designed to operate on PCs within the hospital, ensuring that no sensitive information is transmitted externally.
Q: What was the outcome of the evaluation conducted using past cases from Tohoku University Hospital?: A: In an evaluation using past cases, over 80% of the points presented by the AI technology for EP confirmation and discussion matched the EP's review results regarding treatment policies.